Moreover, in another clinical cohort of ccRCC patients, the expression of DPF3 was found to be significantly higher in metastatic tumors than in primary ones (Supplementary Fig. 1b), suggesting a potential role of DPF3 in tumor metastasis. The gene discussed is DPF3; the disease is metastatic neoplasm.